(Q37463192)

20 August 2017

0 references

Meta-analysis of sentinel lymph node positivity in thin melanoma (<or=1 mm). (English)

1 reference

20 August 2017

0 references

0 references

5

1 reference

20 August 2017

Melanie A Warycha

1

1 reference

20 August 2017

Jan Zakrzewski

2

1 reference

20 August 2017

Quanhong Ni

3

1 reference

20 August 2017

Richard L Shapiro

4

1 reference

20 August 2017

Anna C Pavlick

6

1 reference

20 August 2017

David Polsky

7

1 reference

20 August 2017

Madhu Mazumdar

8

1 reference

20 August 2017

Iman Osman

9

1 reference

20 August 2017

language of work or name

English

0 references

publication date

1 February 2009

1 reference

20 August 2017

1 reference

20 August 2017

115

1 reference

20 August 2017

869-879

1 reference

20 August 2017

4

1 reference

Survival analysis and clinicopathological factors associated with false-negative sentinel lymph node biopsy findings in patients with cutaneous melanoma

20 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3888103

Sentinel-node biopsy or nodal observation in melanoma

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3888103

Sentinel and nonsentinel node status in stage IB and II melanoma patients: two-step prognostic indicators of survival.

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3888103

American Joint Committee on Cancer clinical stage as a selection criterion for sentinel lymph node biopsy in thin melanoma

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3888103

Sentinel node biopsy for thin melanomas: which patients should be considered?

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3888103

Sentinel lymph node biopsy for cutaneous melanoma: the Stanford experience, 1997-2004.

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3888103

Mitotic rate as a predictor of sentinel lymph node positivity in patients with thin melanomas.

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3888103

Sentinel lymph node biopsy in the management of cutaneous head and neck melanoma

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3888103

Sentinel node status in melanoma patients is not predictive for overall survival upon multivariate analysis

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3888103

Indications for lymphatic mapping and sentinel lymphadenectomy in patients with thin melanoma (Breslow thickness < or =1.0 mm).

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3888103

Mitotic rate and younger age are predictors of sentinel lymph node positivity: lessons learned from the generation of a probabilistic model

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3888103

Sentinel lymph node biopsy in patients with Stage I/II melanoma: Clinical experience and literature review.

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3888103

Patterns of recurrence after sentinel lymph node biopsy for cutaneous melanoma

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3888103

Prognosis for patients with thin cutaneous melanoma: long-term survival data from New South Wales Central Cancer Registry and the Sydney Melanoma Unit

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3888103

Methodological index for non-randomized studies (minors): development and validation of a new instrument

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3888103

Revised American Joint Committee on Cancer staging criteria accurately predict sentinel lymph node positivity in clinically node-negative melanoma patients

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3888103

Sentinel lymph node biopsy for the T1 (thin) melanoma: is it necessary?

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3888103

Sentinel lymph node biopsy in patients with thin melanoma

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3888103

Tumour thickness as a predictor of occult lymph node metastases in patients with stage I and II melanoma undergoing sentinel lymph node biopsy.

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3888103

Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3888103

Prognostic factors analysis of 17,600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging system

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3888103

Operating characteristics of a rank correlation test for publication bias

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3888103

Stratification of patients by melanoma cell adhesion molecule (MCAM) expression on the basis of risk: implications for sentinel lymph node biopsy.

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3888103

No indication for performing sentinel node biopsy in melanoma patients with a Breslow thickness of less than 0.9 mm.

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3888103

Sentinel lymph node biopsy in cutaneous melanoma: the WHO Melanoma Program experience

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3888103

Histologic regression in malignant melanoma: an interobserver concordance study

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3888103

Thin malignant melanomas (less than 1.5 mm) with metastasis: a histological study and survival analysis.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3888103

Sentinel lymph node biopsy in patients with thin melanomas.

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3888103

The correlation of regression in primary melanoma with sentinel lymph node status.

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3888103

Sentinel node biopsy in cutaneous melanoma: correlations between melanoma prognostic factors and sentinel node status.

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3888103

Sentinel lymph node biopsy for cutaneous melanoma of the head and neck.

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3888103

Sentinel node biopsy for melanoma: a study of 241 patients.

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3888103

Sentinel node biopsy procedures with an analysis of recurrence patterns and prognosis in melanoma patients: technical advantages using computer-assisted gamma probe with adjustable collimation.

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3888103

Lymphatic mapping and sentinel lymphadenectomy for early-stage melanoma: therapeutic utility and implications of nodal microanatomy and molecular staging for improving the accuracy of detection of nodal micrometastases.

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3888103

Thin melanomas: predictive lethal characteristics from a 30-year clinical experience.

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3888103

Role of sentinel lymph node biopsy in patients with thin (<1 mm) primary melanoma.

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3888103

The New American Joint Committee on Cancer staging system for cutaneous melanoma: a critical analysis based on data of the German Central Malignant Melanoma Registry.

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3888103

Sentinel node biopsy in clinical stage 1 melanoma: rationale for restaging and follow-up.

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3888103

Reliability of the sentinel node procedure in melanoma patients: analysis of failures after long-term follow-up.

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3888103

Melanoma thickness and histology predict sentinel lymph node status

2 September 2018

1 reference

12 December 2020

Histological characteristics of metastasizing thin melanomas: a case-control study of 43 cases

1 reference

12 December 2020

Vertical growth phase and positive sentinel node in thin melanoma

1 reference

12 December 2020

Role of sentinel lymphadenectomy in thin invasive cutaneous melanomas

1 reference

12 December 2020

Tumour regression predicts higher risk of sentinel node involvement in thin cutaneous melanomas

1 reference

12 December 2020

Cost-effectiveness of sentinel lymph node biopsy in thin melanomas

1 reference

12 December 2020

Small cell melanoma and ulceration as predictors of positive sentinel lymph node in malignant melanoma patients

1 reference

12 December 2020

Prognostic factors of thin cutaneous melanoma: an analysis of the central malignant melanoma registry of the german dermatological society

1 reference

12 December 2020

Thin primary cutaneous malignant melanoma: a prognostic tree for 10-year metastasis is more accurate than American Joint Committee on Cancer staging

1 reference

12 December 2020

The prognostic significance of histologic regression in cutaneous melanoma

1 reference

12 December 2020

Patterns of recurrence following a negative sentinel lymph node biopsy in 243 patients with stage I or II melanoma

1 reference

12 December 2020

The importance of mitotic rate as a prognostic factor for localized cutaneous melanoma

1 reference

12 December 2020

Sentinel node metastasectomy in thin <or=1-mm melanoma

1 reference

12 December 2020

A population-based validation of the American Joint Committee on Cancer melanoma staging system

1 reference

12 December 2020

Results of sentinel lymph node biopsy in patients with thin melanoma

1 reference

12 December 2020

Sentinel lymph node biopsy in thin melanoma patients

1 reference

12 December 2020

The prognostic importance of sentinel lymph node biopsy in thin melanoma

1 reference

12 December 2020

Identification of high-risk patients among those diagnosed with thin cutaneous melanomas

1 reference

12 December 2020

Benefit of sentinel lymphadenectomy for patients with nonulcerated cutaneous melanomas in the Breslow range between 0.76 and 1 mm: a follow-up study of 148 patients

1 reference

12 December 2020

Osteopontin as a molecular prognostic marker for melanoma

1 reference

12 December 2020

Primary cutaneous melanoma with regression does not require a lower threshold for sentinel lymph node biopsy

1 reference

12 December 2020

Identifiers

DOI

10.1002/CNCR.24044

1 reference

20 August 2017

1 reference

20 August 2017

1 reference